Variation in structure and delivery of care between kidney transplant centers in the United States

Transplantation

Volumn 98, Issue 5, 2014, Pages 520-528

  Israni, Ajay ^a,b   Dean, Carl E ^a   Salkowski, Nicholas ^c   Li, Suying ^c   Ratner, Lloyd E ^d   Rabb, Hamid ^e   Powe, Neil R ^f   Kim, S Joseph ^g  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Kidney; Pharmacist; Providers; Structure of care; Transplant

Indexed keywords

ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PRACTICE; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH SURVEY; HIGH RISK PATIENT; HLA MATCHING; HOSPITAL CARE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANT CENTER; KIDNEY TRANSPLANTATION; LIVING DONOR; NEPHRECTOMY; NEPHROLOGIST; OUTPATIENT CARE; PHARMACIST; PRIORITY JOURNAL; TISSUE TYPING; ADULT; CROSS-SECTIONAL STUDY; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HUMANS; KIDNEY TRANSPLANTATION; PROCESS ASSESSMENT (HEALTH CARE); UNITED STATES;

EID: 84907597412     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000094     Document Type: Article

References (31)

1. Kidney Disease: Improving Global Outcomes Transplant Work Group, clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1.
2. Chisholm MA, Mulloy LL, Jagadeesan M, et al. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant 2001; 15: 330.
3. Chisholm MA. Enhancing transplant patients' adherence to medication therapy. Clin Transplant 2002; 16: 30.
4. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens andmedication compliance. Clin Ther 2001; 23: 1296.
5. Musgrave CR, Pilch NA, Taber DJ, et al. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant 2013; 13: 796.
6. Vlaminck H, Maes B, Evers G, et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509.
7. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
8. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant. 2004; 4: 1703.
9. Gaston R,Hudson S,Ward M,Jones P,Macon R, eds. Late Renal Allograft Loss: Noncompliance Masquerading as Chronic Rejection. Transplant Proc. 1999; 31: S21.
10. Jarzembowski T, John E, Panaro F, et al. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 2004; 8: 367.
11. Kidney Disease: Improving Global Outcomes Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S38.
12. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657.
13. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998; 36: 1138.
14. Fine R, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009; 9: 35.
15. Morrissey PE, Flynn ML, Lin S. Medication noncompliance and its implications in transplant recipients. Drugs 2007; 67: 1463.
16. Weng LC, Dai YT, Huang HL, Chiang YJ. Self-efficacy, self care behaviours and quality of life of kidney transplant recipients. J Adv Nurs 2010; 66: 828.
17. Curtis BM, Ravani P, Malberti F, et al. The short-and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20: 147. [Comparative Study Research Support, Non-U.S. Gov't].
18. Hemmelgarn BR, Manns BJ, Zhang J, et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 993.
19. Ravani P, Marinangeli G, Tancredi M, et al. Multidisciplinary chronic kidney disease management improves survival on dialysis. J Nephrol. 2003; 16: 870.
20. Thanamayooran S, Rose C, Hirsch DJ. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant 2005; 20: 2385.
21. Goldstein M, Yassa T, Dacouris N, et al. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 2004; 44: 706. [Research Support, Non-U.S. Gov't].
22. Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med 1999; 159: 1939.
23. Martin JE, Zavala EY. The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation. Clin Transplant 2004; 18(Suppl 12): 50.
24. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11(Suppl 15):S1. [Guideline Practice Guideline Research Support, Non-U.S. Gov't].
25. Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2009; 77: 299.
26. Israni A, Snyder J, Skeans M, et al.Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics. Am J Nephrol 2009; 30: 430.
27. Goldade K, Sidhwani S, Patel S, et al. Kidney transplant patients' perceptions, beliefs, and barriers related to regular nephrology outpatient visits. Am J Kidney Dis 2011; 57: 11.
28. Russell C. Culturally responsive interventions to enhance immunosuppressive medication adherence in older African American kidney transplant recipients. Prog Transplant 2006; 16: 187.
29. Schaeffner E, Mehta J, Winkelmayer W. Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis 2008; 151: 811.
30. Weng F, Israni A, Joffe M, et al. Race and electronically-measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005; 16: 1839.
31. Loberiza FR, Zhang M-J, Lee SJ, et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood. 2005; 105: 2979.